# CapsoVision (CV) — News

CV · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/cv/news

## Recent headlines

- [Capsovision: Offering 3.2 mln shares at $5.69 per share for about $18.0 mln gross proceeds - SEC filing](https://www.ainvest.com/news/capsovision-offering-3-2-mln-shares-5-69-share-18-0-mln-gross-proceeds-sec-filing-2609) — AInvest Wire, Sep 18, 2026
  Capsovision Inc. has filed a prospectus with the U.S. Securities and Exchange Commission (SEC) indicating its intention to offer 3.2 million shares at a price of $5.69 per share, generating approximately $18.0 million in gross proceeds . The offering, outlined in the SEC filing, is part of the…
- **Important** — [CVS Health expands collaboration with Salesforce on call center](https://www.ainvest.com/news/cvs-health-expands-collaboration-salesforce-call-center-2605) — AInvest Wire, May 28, 2026
- **Important** — [CVS adds Lilly's Zepbound to preferred drug list in reversal](https://www.ainvest.com/news/cvs-adds-lilly-zepbound-preferred-drug-list-reversal-2605) — AInvest Wire, May 28, 2026
- **Important** — [UBS deals with Carlyle & CVC spark conflict of interest fear](https://www.ainvest.com/news/ubs-deals-carlyle-cvc-spark-conflict-interest-fear-2603-62) — AInvest Wire, Mar 6, 2026
- **Important** — [UBS fee-sharing deals with Carlyle, CVC: FT](https://www.ainvest.com/news/ubs-fee-sharing-deals-carlyle-cvc-ft-2603) — AInvest Wire, Mar 6, 2026

---

Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).